Filter
65
Filtered Results: 65
Text search:
Global
Initiative
for
Chronic
Obstructive
Lung
Disease
(GOLD)
Featured
Recommendations
11
New Publications
17
Language
Document type
No document type
32
Studies & Reports
15
Guidelines
14
Manuals
1
Videos
1
Strategic & Response Plan
1
Fact sheets
1
Countries / Regions
Global
16
Philippines
4
India
4
Tanzania
3
South Africa
3
Nigeria
2
Ethiopia
2
Kenya
1
Ghana
1
Mozambique
1
Guinea-Bissau
1
Germany
1
Western and Central Europe
1
Paraguay
1
Argentina
1
Uganda
1
Eastern Europe
1
Namibia
1
Georgia
1
Angola
1
Botswana
1
Zambia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Guidelines
15
Non-communicable Diseases
15
Policies & Guidelines HIV & TB
9
TB
6
Pediatrics
4
Capacity Building
4
Child Health
2
Policies
2
Drugs & Medical Equipment
2
Paediatrics
1
Public Health
1
Diabetes
1
Humanitarian Aid
1
COVID-19
1
Demograhic Health Surveys DHS
1
Community Health
1
Radiology and Diagnostic
1
Toolboxes
Clinical Aspects & Diagnosis
7
Prevention & Strategies
6
Adults
3
Clinical Guidelines
3
Country Guidelines
2
Essential Medicines & Medical Devices
2
Clinical Aspects & Diagnosis
2
Detection & Diagnosis
2
Childhood TB
1
Curricula & Core Competencies
1
Children
1
Georgia
1
Ethiopia
1
Country specific documents
1
Paediatrics
1
Oxygen Therapy
1
Planetary Health
1
Clean air
1
HIV &TB
1
Environment
1
Overview, Studies & Reports
1
Prevention & Strategies
1
Capacity Building & Resources
1
Information & Education Material (IEC)
1
Studies & Reports
1
Botswana
1
Ghana
1
Disease Prevention & Control
1
Germany
1
Uganda
1
TB
1
Reports & Studies
1
Eastern Europe and central Asia
1
Case Manangement Training Modules
Joining efforts to control two trelated global epidemics.
El objetivo es proveer al equipo de salud, una guía de diagnóstico y terapéutica clínica, tanto farmacológica como no farmacológica, con recomendaciones basadas en evidencia de la mejor calidad disponible y adaptada al marco local.
Los usuarios de la Guía son todos los integrantes del ...
Report of the third conference organized with ICONZ, DFID-RIU, Gates Foundation,
SOS, EU, TDR and FAO with the participation of ILRI and OIE
WHO headquarters, Geneva, Switzerland
23–24 November 2010
In this report we have tried to present the various issues, problems and
challenges that ...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
The "GOLD Patient Guide 2019" explains Chronic Obstructive Pulmonary Disease (COPD), its causes, symptoms, and stages. It provides practical advice for managing COPD, including the importance of quitting smoking, following medical treatment plans, exercising, maintaining a healthy diet, and creating...
The document "Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)" from the IPCRG provides guidance on when to start, adjust, or discontinue ICS in COPD treatment. It highlights the benefits and risks, emphasizing personalized...
The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of GOLD reports is the treatment objectives. These have stood the test of time, and are organized into two groups: objectives tha...
Chronic Obstructive Pulmonary Disease (COPD) is now one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle-income countries (LMICs).
More than 3 million people died of COPD in 2012 accounting for 6% of all deaths globally. COPD represents an important public...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ...
Chronic obstructive pulmonary disease (COPD) is a complex disease that requires differential diagnosis and proper classification to identify appropriate therapy. Nonpharmacologic therapy and preventative measures should be utilized to prevent worsening of disease, symptoms, and complications. The Gl...
These podcasts are produced for educational discussions only. Reference to any specific product, treatment, or entity does not constitute an endorsement. The views expressed by speakers are their own and do not necessarily reflect the view of GOLD in entirety.
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a...
